This is the company’s seventh panel based around therapeutic areas, giving researchers access to panellists diagnosed with one or more of the following: skin cancer, acne, psoriasis, eczema, nail fungus and rosacea. The company also provides access to hard-to-reach healthcare experts including dermatologists, plastic surgeons, oncologists, radiologists, histopathologists and GPs.

“Research Now is committed to improving the ease of collecting quality and actionable insights through its multiple ailments panels,” said Vincent DeRobertis, senior vice president of Global Healthcare (pictured).

“Not only do we provide access to expert opinions from patients concerning a variety of skin conditions and diseases, but we also connect researchers with those involved in the patient journey, including healthcare executives, payers, physicians and specialist nurses.”